基氨酸诱导的脏脂症
Khazeema Hafeez1, Stephan Baker2, Sandeep K Shori3
1Internal Medicine, Baylor Scott & White All Saints Medical Center, Fort Worth, USA.
氧化可以诱导脏脂症,这是由于过度的脂积累导致脏功能障碍的疾病. 这一案例凸显了诊断药物诱导损伤的重要性,以改善患者的治疗结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 脏脂症涉及瘤脂在细胞中的过度积累,可能导致功能障碍.
- 从历史上看,与像法布里病这样的遗传代谢障碍有关,药物诱导的脂症越来越被认可.
- 药物可以触发脂积累,导致细胞功能障碍和功能障碍.
研究的目的:
- 报告Sjogren病患者中氧化诱导的脏脂症病例.
- 调查潜在的慢性病在药物诱导的脂症的发展中的作用.
- 强调准确诊断对于预防进一步的损伤和促进恢复的重要性.
主要方法:
- 一个79岁的患有Sjogren病和脏范围蛋白尿的女性患者的病例介绍.
- 脏活检以确定脂症的形态标志,特别是podocytes中的骨髓状 (状) 体.
- 免疫光染色以排除病理的其他潜在原因.
主要成果:
- 脏活检证实了 podocytes 内的骨髓体,表明脂症.
- 免疫光检测结果对其他原因呈阴性,支持了药物诱导的脂症的诊断.
- 患者已经患有II期慢性病.
结论:
- 氧化可以引起脏脂症,呈现为脏范围蛋白尿症.
- 潜在的慢性病对药物诱导的脂症风险的潜在贡献需要进一步调查.
- 及时诊断和干预对于管理药物诱导的损伤和优化恢复至关重要.
更多相关视频
10:31A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
Published on: September 26, 2025
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
相关概念视频
Nephrotic Syndrome I : Introduction
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
Chronic Kidney Disease II: Clinical Manifestations
Renal Drug Excretion: Tubular Secretion
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Chronic Kidney Disease III: Interprofessional Care
